Hide Board Information

Show Board Information

The Melting Pot

Board Mod: Lotto123

Asst Mods: Da Ghost

Last Post: 09/11/2025 10:11:53 AM

Board Marks: 12

Posts Today: 0

Board Views Today: 41

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

12	ACYD just broke 200dma called 2day @	Buttonwood	02/21/2012 10:57:14 AM
11	Now  I really do not know where I am	Da Ghost	02/21/2012 10:56:48 AM
10	lolzzzzzzzzzzzzzzzzzzzzz....MPot Twighlight Zone	Lotto123	02/21/2012 10:50:23 AM
9	Nice board..marked	junewong	02/21/2012 10:34:02 AM
8	LMAO scary IMO	Keith Stone	02/21/2012 9:25:26 AM
7	lol...WEEEEEEEEEEEEEEEEEEEEEEEEE	Keith Stone	02/21/2012 9:24:37 AM
6	Other Dimensions rock!	Da Ghost	02/21/2012 9:17:13 AM
5	another dimension	Da Ghost	02/21/2012 9:16:38 AM
4	Ah, the Melting Pot home in another	Lotto123	02/21/2012 9:04:52 AM
3	lmao...seriously..hell come soon no	Keith Stone	02/21/2012 1:08:23 AM
2	Oh Boy!!! Where's Sykes... The Melting Pot	11072017	02/21/2012 1:05:23 AM
1	Let the shit show begin lol	Keith Stone	02/21/2012 1:01:31 AM

Newer

Recent Articles

• Promising Results for Rinatabart Sesutecan in Cancer Treatment
• Nuvalent Unveils Promising Insights on Neladalkib for ALK Cancer
• United Airlines Incident: Tarmac Collision at O'Hare Airport
• Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
• Clinical Breakthrough: ITM's Promising Trial Results Unveiled
• Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
• New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
• Concerns Raised Over Elon Musk's Striking Compensation Package
• Qustodio: Elevating Digital Child Safety on iPhones in 2025
• Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
• Innovative Gedatolisib and Darolutamide Study Shows Promise
• New Insights on Gedatolisib's Role in Breast Cancer Treatment
• Meta and Blue Owl Collaborate on $30 Billion AI Data Center
• Kura Oncology's Latest Insights on FTI Program Advancements
• Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
• Kura Oncology Unveils Promising Data from FTI Programs at ESMO
• Olema Oncology Shares Promising Findings on Palazestrant
• General Oncology's SHARON Trial Yields Encouraging Results
• Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
• Corbus Pharmaceuticals Reports Promising Results for CRB-701
• Promising Data on NX-1607: A Breakthrough in Cancer Treatment
• Florida Cancer Specialists Revolutionizing Oncology Research
• Salesforce CEO's Apology Sparks Controversy in Tech Industry
• Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
• Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
• Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment
• Trump's Decision on Ukraine Missiles Revealed After Key Talks
• Kevin O'Leary Highlights Importance of American Dream for Leadership
• Transformational Program for Millennial Professionals Unveiled
• Investigation Launched as PeopleGuru Faces Data Breach Crisis
• Trump Seeks Supreme Court Approval for National Guard in Chicago
• Westhaven Gold Corp. Announces Executive Update and Future Plans
• Trump Commutes Santos' Prison Sentence Amid Public Support
• A New Toolkit to Enhance Executive Function Skills in Education
• Westhaven Gold Announces Leadership Changes and Operations Update
• Aeroméxico's Exciting Global Offering: What You Need to Know
• Investigation Into Luminar Technologies Signals Serious Concerns
• Inquiry into Hasbro Leadership: Legal Investigation Unfolds
• Legal Investigation of CVS/Aetna Medicare Advantage Claims
• Deadline Approaches for Dow Investors in Class Action Case
• Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
• Fluor Corporation Lawsuit Update: Important Investor Info
• Investors Urged to Act Before KBR Class Action Deadline
• Cytokinetics Class Action Lawsuit Update: Important Deadlines
• Important Legal Update for WPP Investors: Key Deadline Approaches
• Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
• Marex Group Faces Class Action Lawsuit Over Financial Misconduct
• Lead the Charge: Join the Fly-E Group Securities Lawsuit
• Investigation into MoonLake Immunotherapeutics Raises Concerns
• MoonLake Immunotherapeutics: Investors Investigate Potential Fraud